Long post, sorry. Egrifta (tesamorelin): what actually has human evidence behind it, and what is extrapolation from animals?
What surprised me is how much of the perceived benefit was routine and attention rather than pharmacology.
Mechanism is not outcome, and a plausible pathway is the most expensive kind of evidence there is.
Anyone got a paper worth reading on this rather than a write-up of a paper?
Nobody has ever been talked out of a stack by a stranger on the internet.
Same here.
Same for me with tesamorelin, unfortunately.
Loose evidence and no evidence are different, and people overcorrect in both directions.
Underdosing and tolerance are indistinguishable from the inside, and everyone picks the flattering explanation.
How long before you can reasonably say something is or is not doing anything?